Health Industry

Latest KFF Health News Stories

Podcast: KHN’s ‘What The Health?’ Reading The Tea Leaves In Blue Wave’s Wake

KFF Health News Original

In this episode of KHN’s “What the Health?” Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times, Alice Ollstein of Politico and Anna Edney of Bloomberg News discuss the impact of House Democratic leadership elections and their impact on health policy; as well as efforts by the Trump administration to address high drug prices and ensure the safety of medical devices. Plus, Julie Rovner interviews KHN’s Jay Hancock about the latest “Bill of the Month.”

Chronically Ill, Traumatically Billed: The $123,000 Medicine For MS

KFF Health News Original

Shereese Hickson’s doctor wanted her to try the infusion drug Ocrevus for her multiple sclerosis. Even though Hickson is trained as a medical billing coder, she was shocked to see two doses of the drug priced at $123,019, with her share set at $3,620.

Buyers Of Short-Term Health Plans: Wise Or Shortsighted?

KFF Health News Original

Policyholders reason that their health is good — for now — and they don’t see the need for costly comprehensive coverage. Detractors say the plans undermine the Affordable Care Act, and agents advise reading the fine print. “You basically have to be in perfect health,” says one.

Playing On Fear And Fun, Hospitals Follow Pharma In Direct-To-Consumer Advertising

KFF Health News Original

Hospitals are increasingly advertising medical services directly to patients to enhance their national brands. They think the image building improves their ability to negotiate with health plans and brings in wealthier patients.

An Underused Strategy For Surge In STDs: Treat Patients’ Partners Without A Doctor Visit

KFF Health News Original

For over a decade, federal health officials have recommended the practice, known as expedited partner therapy. It is allowed in most states, but many doctors don’t do it — either because of legal or ethical concerns, or because they are unaware of it.

Measure To Cap Dialysis Profits Pummeled After Record Spending By Industry

KFF Health News Original

The dialysis industry raised nearly $111 million in a successful bid to defeat the measure, which also was opposed by hospitals and doctors. The union that sponsored the measure collected about one-sixth that amount.